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    Key messages
▶  The number of people diagnosed 
with diabetes mellitus has risen.
▶  9 % of women and 8 % of men 
have ever been diagnosed with 
diabetes – corresponding to a 
total of 6 million adults in Ger-
many.
▶  In Germany there is not only 
an east-west decline, but also 
a north-south decline in the  
prevalence of diagnosed diabetes.
▶  Some diabetes complications 
are declining, e. g. blindness, 
amputations and severe preg-
nancy complications. 
▶  Efforts to improve diabetes care 
have been intensified.
Diabetes mellitus in Germany 
Diabetes mellitus – a metabolic disorder that is now common all over the world – 
is characterized by elevated blood sugar concentrations. There are different types 
of diabetes, which are caused by insulin deficiency or impaired insulin action. 
Insufficient control of the blood sugar level can cause serious damage to the blood 
vessels and peripheral nerves. 
The socio-economic importance of diabetes arises from the resultant severe 
long-term complications, the partial disability, the reduction in quality of life and 
life expectancy, and the need for medical treatment. The main complications of 
diabetes – which the St Vincent Declaration has targeted to reduce – are coronary 
heart disease, blindness, kidney failure and amputations of the lower limbs (WHO, 
IDF 1990).
The following overview focuses on diabetes mellitus in adults, which in 80 % 
to 90 % of cases occurs as type 2 diabetes. This type of diabetes usually develops 
among older adults, but is increasingly being observed in younger age groups. It is 
based on an interaction between genetic predisposition and environmental factors 
(particularly lack of exercise, unfavourable dietary habits and overweight). In cases 
of type 2 diabetes the effect of insulin is impaired and may be combined with an 
insufficient insulin secretion. 
Type 1 diabetes, which is characterized by an autoimmune destruction of the 
insulin-producing cells, occurs predominantly in childhood and adolescence. It can 
also be found in adults as what is known as »latent autoimmune diabetes in adults« 
(LADA). Other types of diabetes include gestational diabetes – which occurs for the 
first time in pregnancy and usually regresses after birth – and specific, very rare 
types caused by genetic defects or specific diseases (Kerner, Brückel 2010).
The information provided below on the prevalence of diabetes in the German 
adult population is based on data from the »German Health Update« (GEDA), a 
telephone health survey conducted by the Robert Koch Institute (RKI) in 2009 
(Kurth et al. 2009). The prevalence of diabetes complications is presented by 
including results from the RKI's 2003 telephone health survey »GSTel03«. The 
article also tracks the trend in prevalence of diabetes and its complications since 
the 1990s. Finally, aspects of diabetes care are examined using data from various 
other sources. 
A total of 9 percent of the adult population suffer from diabetes
In the 2009 GEDA study, the German population aged 18 years and older living 
in private households was asked whether a physician had ever diagnosed a dia-
betes (lifetime prevalence). A total of 8.8 % of adults – 9.3 % of the women and 
8.2 % of the men – stated a diagnosis of diabetes. Extrapolating these results to 
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the adult population in Germany (per 31 December 2007) 
suggests that 5.98 million adults have ever been diagnosed 
with diabetes. 
High prevalence among adults aged over 50 years 
In both sexes, the prevalence of diabetes is less than 5 % 
among people aged up to 40-49 years, but strongly incre-
ases in the older age groups: diabetes was reported from 
one in eleven among the 50- to 59-year-olds, one in seven 
among the 60- to 69-year-olds, and as many as one in five 
people among the over-70s (Figure 1). 
Regional differences in the prevalence of diabetes 
In the 2009 GEDA study, 11.5 % of the women and 9.5 % of 
the men in eastern Germany (including Berlin) reported 
that they had ever been diagnosed with diabetes, reflecting 
that they were more frequently affected by diabetes than 
women and men in western Germany (excluding Berlin), 
where the figures were 8.7 % and 7.9 %, respectively. An 
analysis at the regional level also points to north-south 
differences in the prevalence of diabetes among the adult 
population (Figure 3).
Increase in diabetes prevalence 
By including previous RKI health surveys it was feasible 
to trace the temporal development of the prevalence of 
diagnosed diabetes since 1990/92 among the population 
aged 25-69 years. Up until a few years ago (1990/92 to 
2003/05), there was no statistically significant trend, at least 
not for this age group (Heidemann et al. 2009). When the 
latest data from the 2009 GEDA are included, however, 
a significant increase in diabetes prevalence among the 25- 
to 69-year-olds can be shown for the first time at the popula-
tion level (RKI 2009a). The increase is even stronger when 
adults from the age of 18 years with no upper age limit are 
examined (Table 1). However, because of the different age 
Figure 1 
Gender-specific prevalence of diagnosed diabetes, by age group
Data basis: GEDA 2009
Diabetes prevalence rises with decreasing 
educational status 
Ascertainment of school education and vocational trai-
ning in the 2009 GEDA study facilitate to examine the 
prevalence of diabetes in relation to a person's educational 
status (CASMIN Index, Braun et al. 2003). The results 
show a rising prevalence of diabetes as educational status 
decreases. This association is most evident among women 
above the age of 50 years (Figure 2). 
Figure 2
Gender-specific prevalence of diagnosed diabetes, by educational status and age group 
Data basis: GEDA 2009
German Health Update (GEDA) 
Data holder: Robert Koch Institute
Objectives:  To provide up-to-date data on 
health-related issues, to analyse 
temporal developments and trends  
Survey method:  Computer-assisted telephone  
interviews (CATI)
Population:  Residential population of Germany 
aged 18 and over
Sample:  21,262 women und men
Cooperation rate:  51.2 % 
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had ever had typical diabetes complications. Over 10 % of 
the participants with diabetes stated (acute) severe hypo- 
glycaemia. The most commonly reported long-term com-
plications were heart complications, followed by diabetic 
eye disease, diabetic neuropathy, diabetic foot syndrome, 
diabetic kidney disease and amputations (Table 2). In total, 
about half of the people with diabetes stated that they had 
not experienced any of these complications to date (Burger, 
Tiemann 2005). 
Partial success in achieving the St Vincent objectives 
Analyses of regional disease data and health insurance 
data indicate that there has been at least a partial reduction 
in the occurence of some serious diabetes complications 
over time, as envisaged by the 1989 St Vincent Declaration.
Although people with diabetes still suffer blindness, 
amputations, kidney failure, heart disease and pregnancy 
complications much more frequently than non-diabetics, 
the incidence rates of blindness (Genz et al. 2010) and 
amputations (Icks et al. 2009a) and the frequency of seve-
re pregnancy complications (Beyerlein et al. 2010) have 
declined since the 1990s – to a greater extent among dia-
betics than non-diabetics. This observation was not made 
regarding renal failure (Icks et al. 2011) or heart disease 
(Icks et al. 2009b). 
limits on recruiting participants in earlier health surveys, 
only two observation periods can be examined in this com-
parison: the GSTel03 survey conducted in 2002/03 and the 
2009 GEDA study. 
The observed increase in diabetes prevalence is parti-
ally (about one-fifth) due to the 'ageing' of the population. 
However, even over and above demographic ageing there 
was a statistically significant increase in diabetes prevalence 
between 2003 and 2009.
Heart disease is most common long-term complication 
In the »GSTel03« telephone health survey, participants 
with physician-diagnosed diabetes were asked whether they 
Table 2
Prevalence of complications among adults aged 18 years and older who 
have been diagnosed with diabetes, as a percentage 
Data basis: GSTel03 (Burger, Tiemann 2005)
Diabetes complications* Women Men
Severe hypoglycaemia 14.7 % 11.6 %
Heart complications 26.0 % 20.6 %
Diabetic eye disease 15.5 % 13.9 %
Diabetic neuropathy 11.8 % 9.2 %
Diabetic foot syndrome 6.5 % 7.4 %
Diabetic kidney disease  4.6 % 2.3 %
Amputation 1.4 % 2.6 %
Figure 3 
Prevalence of diagnosed diabetes, by region (Nielsen areas)
Data basis: GEDA 2009
Growing efforts to improve the quality of diabetes care 
To date there are no nationwide data available assessing 
the extent to which the St Vincent Declaration targets have 
been met in diabetes care. The results of various studies 
described above, however, indicate that some progress has 
been made. This is probably due in part to the conside-
rable efforts made in recent years to structure diabetes 
care and to integrate diabetes care into a comprehensi-















Prevalence of diagnosed diabetes among the adult population aged 18 ye-
ars and older (percent, 95% confidence interval) 
Data basis: GSTel03 und GEDA 2009 (RKI 2010)
* weighted according to the respective representative population
* as formulated in the GSTel03 interview
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about 210,000 per annum between 2000 and 2009. It is 
believed, however, that these data underestimate the impor-
tance of diabetes as the underlying disease for hospitaliza-
tion. Often not the diabetes, but one of its complications is 
entered in official statistics as the responsible primary diag-
nosis. Furthermore, when assessing time series, it must also 
be kept in mind that changes made for technical, invoicing 
reasons can have an effect on the number of cases via the 
Diagnosis Related Group (DRG) system. 
Diabetes is one of Germany's most expensive chronic 
diseases 
The Federal Statistical Office estimates that the direct costs 
of caring for diabetes patients in Germany (outpatient and 
inpatient treatment, nursing, rehabilitation services and 
drugs) totalled € 6.34 billion in 2008. This corresponds to 
a 2.5 % of health expenditure for all diseases (Federal Sta-
tistical Office 2011b). Over time, the direct costs of diabetes 
gradually increased.For example, diabetes-related costs in 
2008 were 28 % higher than in 2002 – while the costs of 
all diseases had increased by only 16 %. Expenditures on the 
treatment of diabetic complications and secondary diseases 
were not included in these estimates. 
When these expenditures are also taken into account, 
the direct costs – in accordance with the Costs of Diabetes 
Mellitus (CoDiM) study – are probably about three times 
higher (for 2007: €19.1 billion) (Köster et al. 2011). Further, 
when the indirect costs resulting from diabetes (loss of 
resources through disability or early retirement) are also 
included, total costs could be as much as four times higher 
(Hauner 2006).
Conclusion and outlook 
The presented data show that the prevalence of diagnosed 
diabetes in the adult population of Germany increased 
between 2003 and 2009. This increase can be partly exp-
lained by the »ageing« of the population. The role played 
by additional factors (such as an increasing prevalence of 
diabetes risk factors, improved measures for early diag-
nosis and improved treatment) needs to be investigated. 
Moreover, there are signs of improvement in diabetes 
care in terms of both care processes and care outcomes. At 
the same time, however, there are indications that diabetic 
patients with a high risk of complications are not being 
reached via the structured DMP care service (Schafer et 
al. 2010). 
When interpreting the diabetes prevalence estimates 
given above, it should be noted that the available data 
do not allow an estimation that includes the prevalence 
of undiagnosed diabetes. Yet this would be necessary to 
assess the overall disease burden associated with diabetes 
mellitus. An increase in the prevalence of diagnosed dia-
betes in Germany could largely be the result of improved 
health education and earlier diagnosis. The prevalence 
ment programmes (DMPs) for type 2 and type 1 diabetes 
introduced in 2003 and 2004 are essential components 
in this context. By February 2011 a total of 3.43 million 
people were enrolled in a DMP for type 2 diabetes and 
138,000 people in a DMP for type 1 diabetes. In additi-
on, the National Disease Management Guidelines Pro-
gramme for type 2 diabetes (DM-CPG Programme) was 
revised into the form of modules aimed at diagnosing and 
treating specific diabetes complications and encouraging 
patients to become actively involved in their diabetes care 
(http://www.diabetes.versorgungsleitlinien.de). 
Further, indicators are currently being developed in 
Germany to describe the quality of care in line with cen-
tral recommendations of the DM-CPG Programme to 
facilitate to put the guidelines into practice and to evalu-
ate their effect on the quality of diabetes care (Nothacker 
et al. 2011). However, this does not mean that the develop-
ment of the quality indicators for diabetes care is complete 
(http://www.aqua-institut.de). 
Improvement in the implementation of services for 
diabetes care possible
The GSTel03 data are the most recent available nationwide 
survey data providing information on the extent to which 
treatment and care services are actually received by people 
with diabetes. All participants who had reported a diagnosis 
of diabetes were asked about the type of treatment they were 
currently receiving. Altogether, only one in seven (14 %) 
stated a treatment based on changes in diet and/or physical 
activity only (Burger, Tiemann, 2005) – although lifestyle 
modifications should be a main focus in the treatment of 
persons with type 2 diabetes (which represent the largest 
portion among all persons with diabetes). For almost half 
of the participants with diabetes the treatment was based 
on a combination of lifestyle modification and drug treat-
ment, either using tablets (26 %) or insulin (14 %) or both 
tablets and insulin (5 %). 14 % of the participants with dia-
betes were treated exclusively with medication. According 
to self-reports, about one in ten (11 %) were not treated at all, 
In the GSTel03 survey, participants diagnosed with diabe-
tes were also asked about the frequency of important health-
care measures. On average, more than half reported that their 
HbA1c was measured less frequently than once a quarter; 
about 10 % stated that it had not been measured at all in the 
last 12 months. About 70 % of the participants with diabetes 
reported that their eyeground had been measured during the 
last 12 months, but only just under half reported a medical 
foot examination. Only about one in four (28 %) received all 
three services. 
Diabetes is one of the most frequent primary diagno-
ses in hospitals
According to hospital statistics, the total number of diabetes 
cases treated as inpatients remained relatively constant at 
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of undiagnosed diabetes would correspondingly tend to 
remain constant or even decline – a trend that has been 
observed in the USA and the UK, for example (Gregg et al. 
2004, Pierce et al. 2009). 
To date, estimates on the prevalence of undiagnosed dia-
betes in Germany have only been available from regional 
studies in the Augsburg area. On the basis of a standardized 
glucose tolerance test, a prevalence of undiagnosed diabetes 
was observed in subsamples of the KORA cohort that was 
just as high as the prevalence of diagnosed diabetes (Rath-
mann et al. 2003, Meisinger et al. 2010). The Robert Koch 
Institute's ongoing »Adult Health in Germany« (DEGS) 
study, which includes at least measurements of fasting glu-
cose in a subsample of the study participants, will be able to 
contribute nationwide data for the first time (RKI 2009b). 
In the context of continuous health monitoring, the RKI's 
recurring, population-representative cross-sectional surveys 
will also be able to contribute important data on diabetes 
prevalence and the utilization of diabetes-specific care servi-
ces in the future. In addition, regularly available data on the 
incidence of type 2 diabetes, and its organ complications and 
on regional care processes and structures will be needed for 
a comprehensive surveillance of the disease and the quality 
of care in Germany. This would facilitate to identify special 
needs at the regional level in a much more differentiated way 
and meet them by allocating resources accordingly.
As long as the corresponding data are only partially availa-
ble, it will be necessary to resort to other data sources. For 
example the Organization for Economic Cooperation and 
Development (OECD) has proposed estimating the quality of 
care of chronic diseases with a high care potential via the rate 
of avoidable hospital admissions, which are defined in the 
case of diabetes as hospital admissions due to acute diabetes-
specific complications (Drösler, Scheidt-Nave, 2010). 
A consortium of regional (SHIP, KORA S4/F4, MONI-
CA, CARLA, DGS, HNR) and nationwide population-
representative health studies (BGS98, DEGS) has been 
achieved within the Competence Network Diabetes Mellitus 
(http://www.kompetenznetz-diabetes-mellitus.net). Baseline 
data of this consortium allow to investigate regional differen-
ces in the prevalence of diagnosed diabetes mellitus and the 
influence of socio-demographic differences. 
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